Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds
Open Access
- 21 October 2011
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 3 (1) , 224-228
Abstract
Breast cancer remains a therapeutic challenge, and this has intensified the search for new drug targets. The AMP-activated protein kinase (AMPK) signalling pathway is emerging as having potential for intervention. We assessed the possible different effects of AMPK action on breast cancer cells by studying their impact on proliferation, apoptosis and the mitochondrial membrane potential in three breast cancer cell lines (MCF-7, MDA-MB-231 and T47D) differing in their p53 and estrogen receptor (ER) status. Activation of AMPK by 5-aminoimidazole carboxamide ribonucleotide (AICAR) and phenformin elicited clear anti-proliferative effects in all breast cancer cell lines, but with differences in sensitivity. However, the anti-proliferative effects were accompanied by varying responses between the different cells, with a marked cell cycle arrest effect in T47D cells and an apoptotic effect in MCF-7 and MDA-MB-231 cells. The mitochondrial apoptotic pathway was potentially involved in all cell lines. These results suggest that AMPK potentially serves as a therapeutic target in breast cancer, but one which may be dependent on the genetic background of the cancer cells.Keywords
This publication has 15 references indexed in Scilit:
- Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonistsEuropean Journal of Endocrinology, 2009
- AMPK: Lessons from transgenic and knockout animalsFrontiers in Bioscience-Landmark, 2009
- Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brainMolecular Cancer, 2008
- Breast cancer risk-assessment modelsBreast Cancer Research, 2007
- Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapyMolecular Cancer, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- AMPK, the metabolic syndrome and cancerTrends in Pharmacological Sciences, 2005
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanismsBiochemical and Biophysical Research Communications, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001